{Reference Type}: Journal Article
{Title}: Mammalian START-like phosphatidylinositol transfer proteins - Physiological perspectives and roles in cancer biology.
{Author}: Pathak A;Willis KG;Bankaitis VA;McDermott MI;
{Journal}: Biochim Biophys Acta Mol Cell Biol Lipids
{Volume}: 1869
{Issue}: 7
{Year}: 2024 Oct 28
{Factor}: 5.228
{DOI}: 10.1016/j.bbalip.2024.159529
{Abstract}: PtdIns and its phosphorylated derivatives, the phosphoinositides, are the biochemical components of a major pathway of intracellular signaling in all eukaryotic cells. These lipids are few in terms of cohort of unique positional isomers, and are quantitatively minor species of the bulk cellular lipidome. Nevertheless, phosphoinositides regulate an impressively diverse set of biological processes. It is from that perspective that perturbations in phosphoinositide-dependent signaling pathways are increasingly being recognized as causal foundations of many human diseases - including cancer. Although phosphatidylinositol transfer proteins (PITPs) are not enzymes, these proteins are physiologically significant regulators of phosphoinositide signaling. As such, PITPs are conserved throughout the eukaryotic kingdom. Their biological importance notwithstanding, PITPs remain understudied. Herein, we review current information regarding PITP biology primarily focusing on how derangements in PITP function disrupt key signaling/developmental pathways and are associated with a growing list of pathologies in mammals.